197 related articles for article (PubMed ID: 21326611)
41. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises.
Sarmento LM; Barata JT
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1403-15. PubMed ID: 21929314
[TBL] [Abstract][Full Text] [Related]
43. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
[TBL] [Abstract][Full Text] [Related]
44. Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines.
Cecchinato V; Erba E; Basile A; Scarpati B; Fazi C; Brando B; Comi P; Chiaramonte R
Leuk Res; 2008 May; 32(5):791-7. PubMed ID: 17964649
[TBL] [Abstract][Full Text] [Related]
45. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
46. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
Weng AP; Millholland JM; Yashiro-Ohtani Y; Arcangeli ML; Lau A; Wai C; Del Bianco C; Rodriguez CG; Sai H; Tobias J; Li Y; Wolfe MS; Shachaf C; Felsher D; Blacklow SC; Pear WS; Aster JC
Genes Dev; 2006 Aug; 20(15):2096-109. PubMed ID: 16847353
[TBL] [Abstract][Full Text] [Related]
47. NOTCH1-induced T-cell leukemia in transgenic zebrafish.
Chen J; Jette C; Kanki JP; Aster JC; Look AT; Griffin JD
Leukemia; 2007 Mar; 21(3):462-71. PubMed ID: 17252014
[TBL] [Abstract][Full Text] [Related]
48. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
[TBL] [Abstract][Full Text] [Related]
49. miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia.
Saccomani V; Grassi A; Piovan E; Bongiovanni D; Di Martino L; Minuzzo S; Tosello V; Zanovello P
Cells; 2020 Jul; 9(7):. PubMed ID: 32708470
[TBL] [Abstract][Full Text] [Related]
50. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
[TBL] [Abstract][Full Text] [Related]
51. TLX1/HOX11-induced hematopoietic differentiation blockade.
Riz I; Akimov SS; Eaker SS; Baxter KK; Lee HJ; Mariño-Ramírez L; Landsman D; Hawley TS; Hawley RG
Oncogene; 2007 Jun; 26(28):4115-23. PubMed ID: 17213805
[TBL] [Abstract][Full Text] [Related]
52. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
[TBL] [Abstract][Full Text] [Related]
53. A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene.
Greene WK; Sontani Y; Sharp MA; Dunn DS; Kees UR; Bellgard MI
Gene; 2007 Apr; 391(1-2):223-32. PubMed ID: 17303350
[TBL] [Abstract][Full Text] [Related]
54. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
Kleppe M; Soulier J; Asnafi V; Mentens N; Hornakova T; Knoops L; Constantinescu S; Sigaux F; Meijerink JP; Vandenberghe P; Tartaglia M; Foa R; Macintyre E; Haferlach T; Cools J
Blood; 2011 Jun; 117(26):7090-8. PubMed ID: 21551237
[TBL] [Abstract][Full Text] [Related]
55. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis.
Funahashi Y; Hernandez SL; Das I; Ahn A; Huang J; Vorontchikhina M; Sharma A; Kanamaru E; Borisenko V; Desilva DM; Suzuki A; Wang X; Shawber CJ; Kandel JJ; Yamashiro DJ; Kitajewski J
Cancer Res; 2008 Jun; 68(12):4727-35. PubMed ID: 18559519
[TBL] [Abstract][Full Text] [Related]
56. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
[TBL] [Abstract][Full Text] [Related]
57. Association of TLX1 gene polymorphisms with the risk of acute lymphoblastic leukemia and B lineage acute lymphoblastic leukemia in Han Chinese children.
Mei E; Wei X; Gao J; Tian X; Li W; Liu L; Qian C
J Clin Lab Anal; 2020 Sep; 34(9):e23414. PubMed ID: 32488880
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.
Palomero T; Ferrando A
Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S205-10. PubMed ID: 19778842
[TBL] [Abstract][Full Text] [Related]
59. The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.
Tan Y; Sementino E; Xu J; Pei J; Liu Z; Ito TK; Cai KQ; Peri S; Klein-Szanto AJ; Wiest DL; Testa JR
Oncotarget; 2017 Feb; 8(9):14941-14956. PubMed ID: 28122332
[TBL] [Abstract][Full Text] [Related]
60. The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.
Zweier-Renn LA; Riz I; Hawley TS; Hawley RG
J Bone Marrow Res; 2013 Feb; 1():. PubMed ID: 25309961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
